ENTBF

ENTHEON BIOMEDICAL CORP by ENTHEON BIOMEDICAL CORP. (ENTBF)

About ENTHEON BIOMEDICAL CORP by ENTHEON BIOMEDICAL CORP. (ENTBF)

Entheon Biomedical Corp. operates as a biotechnology research and development company. The firm engages in developing and commercializing dimethyltryptamine based psychedelic therapeutic products. Its therapies aim to treat addiction and substance use disorders. The company was founded on April 6, 2010 and is headquartered in Vancouver, Canada.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.29
52 Week Low
$0.02
Market cap
874,500
Dividend yield
0.00%
Volume
40
Avg. volume
182
P/E ratio
-2.10

ENTHEON BIOMEDICAL CORP by ENTHEON BIOMEDICAL CORP. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.29
52 Week Low
$0.02
Market cap
874,500
Dividend yield
0.00%
Volume
40
Avg. volume
182
P/E ratio
-2.10